#ibudilast

Progressi terapeutici nella SLA: l’obiettivo è colpire l’infiammazione e l’ossidazione

La sclerosi laterale amiotrofica (SLA), nota anche come malattia di Lou Gehrig, è una malattia neurodegenerativa che colpisce circa 5.000 persone negli Stati Uniti ogni anno. Circa il 10% dei casi di SLA è ereditario o familiare, spesso causato da un errore nel gene C9orf72. Rispetto alla SLA sporadica o non familiare, si ritiene che i pazienti C90rf72 abbiano un decorso della malattia più…

Mavenclad for multiple sclerosis

I had a visual appointment with my MS specialist yesterday. She is the one who prescribes and advises on my main MS drug therapy. Currently I am on Rituxan. The question of my disability getting worse really isn’t a question, it is a fact. We’ve discussed other drugs but unfortunately the one she was waiting for is still a few years off. That’s the Ibudilast. She did yesterday for the first time…

Ocrevus, Rituxan not new drugs

I received an email yesterday about a new drug for progressive MS called Ocrevus. https://www.cbsnews.com/video/new-drug-provides-hope-for-those-suffering-with-ms/I don’t get it, I’ve been on Ocrevus for almost 2 years already. Is it really still new news?

I wish I could rave about this drug that it has done wonders for me, but it hasn’t. I haven’t had any relapses and for that I am thankful but…

Rituxan instead of Ocrevus

Going to see my neurologist, on my mind was questions of whether to stay on Ocrevus. I felt if I was still declining so much why be on a drug that can come with some serious side effects. Was the pros still out weighing the cons. I had two other drugs in mind Siponimod and Ibudilast. Both drugs are coming out for secondary progressive.

My neuro shot down Siponimod because I was on Gilyenia and it…

My neurological tests don’t show my ms progression, why?

It is tough. I go to the doctor and my neurological tests aren’t so bad from my last visit. My timed walking was increased by only 2 seconds. No big deal. My range of motion was pretty much the same range as it was last visit. My MRI shows no activity. Yet I’m worse. Everyone who is involved in my daily life knows I’m worse. It’s frustrating. It’s not like my doctor doesn’t believe me. It’s not…

Is Ocrevus still right for me?

I have an appointment tomorrow morning in NYC with my MS specialist. I’m coming off a 3 day round of steroids to see if it was at all possible I could be having some type of relapse. I personally didn’t believe that’s what was happening, however I believe steroids can you give me a little bump up in the energy. My thought going into tomorrow is if I’m still deteriorating so much, why am I taking…

¿Puede detenerse la esclerosis múltiple progresiva con el Ibudilast?

Aunque se han aprobado más de una docena de terapias para el tratamiento de formas recurrentes de esclerosis múltiple, solo el anticuerpo monoclonal ocrelizumab y el agente de quimioterapia mitoxantrona están aprobados para la esclerosis múltiple progresiva. 

1 Ibudilast es una molécula pequeña disponible en Asia, para el tratamiento del asma y el vértigo . 

El ibudilast inhibe varias…

Visit Now - https://zeroviral.com/brief-medicinova-announces-phase-2b-trial-results-in-mn-166-ibudilast/

BRIEF-Medicinova Announces Phase 2B Trial results in MN-166 (Ibudilast)

Feb 1 (Reuters) – Medicinova Inc:

* MEDICINOVA ANNOUNCES MN-166 (IBUDILAST) DEMONSTRATED A 26 PCT REDUCTION IN CONFIRMED DISABILITY PROGRESSION IN THE SPRINT-MS PHASE 2B TRIAL IN PROGRESSIVE MS: POTENTIAL BEST-IN-DISEASE DRUG Source text for Eikon: Further company coverage: